AIM ImmunoTech Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
AIM ImmunoTech Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for AIM ImmunoTech were recently set by distinguished experts, with an average mark of $2.75. If it reached this goal, it would represent a potential upside of approximately 539.53% from the previous closing price in April, 2024. The high end is $3.50, and the low is $2.00. You may be interested in rivals even if you aren't interested in AIM ImmunoTech stock.
539.53% Upside
AIM ImmunoTech Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, AIM ImmunoTech's Price has grown, increasing from $0.00 to $0.00 – an increase of 100.00%. For next year, the 2 analysts predict Fair Value of $0.46, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is Fair Valueof $0.87, which would mean a seven-year growth forecast of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MRK Stock Forecast | Merck | Outperform |
2
|
$131.20 | Buy/Sell | $130.51 | 8.61% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£119.88 | Buy/Sell | £165.99 | 35.93% |
| NOVN Stock Forecast | Novartis | Hold |
10
|
CHF89.50 | Buy/Sell | CHF105.00 | 20.25% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.40 | Buy/Sell | $32.87 | 20.08% |
| GSK Stock Forecast | GSK | Outperform |
12
|
£16.53 | Buy/Sell | £17.30 | 17.97% |
AIM ImmunoTech Revenue Forecast for 2023 - 2025 - 2030
In the last two years, AIM ImmunoTech has seen a decline in its Revenue, from $160.00k to $140.00k – a 12.50% decrease. According to the 3 analysts polled, in the next year, AIM ImmunoTech's Revenue will fall by 42.86%, reaching $80.00k. Over the next seven years, the pros' prediction is Revenueof $225.34M, which would mean a seven-year growth forecast of 160857.14%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$40.13 | Buy/Sell | $44.86 | 12.14% |
| SRPT Stock Forecast | Sarepta Therapeutics | Outperform |
6
|
$128.77 | Buy/Sell | $158.66 | 28.52% |
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$31.94 | Buy/Sell | $44.75 | 23.98% |
.jpg)
AIM ImmunoTech EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, AIM ImmunoTech's EBITDA has grown by 39.21%, from $-14.13M to $-19.67M. In the following year, 0 experts forecast AIM ImmunoTech's EBITDA will decrease by 15.89%, to $-16.54M. In 2030, professionals predict that AIM ImmunoTech's EBITDA will decrease by 14.55%, to $-16.81M.
AIM ImmunoTech EBIT Forecast for 2023 - 2025 - 2030
In the last two years, AIM ImmunoTech's EBIT has grown from $-14.86M to $-19.92M – a 34.05% increase. Next year, analysts are expecting EBIT to reach $-23.83M – an increase of 19.63%. Professionals believe that By 2030, AIM ImmunoTech's EBIT will fall to $126.84M– a 736.75% decrease from its current value.
AIM ImmunoTech EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, AIM ImmunoTech's EPS has grown, increasing from $-0.49 to $0.00 – an increase of 100.00%. For next year, the 2 analysts predict EPS of $-0.45, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is EPSof $-0.42, which would mean a seven-year growth forecast of 100.00%.
.jpg)